Hyperbilirubinemia Treatment Guidelines
Phototherapy
- Phototherapy is the primary treatment for hyperbilirubinemia, which safely and effectively decreases total serum bilirubin concentrations within 4-6 hours of initiation when properly administered, according to the American Academy of Pediatrics 1, 2
- Phototherapy should be delivered using blue-green light in the 460-490 nm wavelength range (optimal peak at 478 nm) 1, 2
- Effective phototherapy requires an irradiance of 25-35 mW/cm²/nm delivered to at least one surface of the body (ventral or dorsal) 1, 2
- LED light sources are preferred as they deliver specific wavelengths in narrow bandwidths with minimal heat generation 1
- Maximize exposed body surface area (35-80% of total body surface) by changing the infant's position every 2-3 hours 3
- Avoid obstructing light with equipment such as radiant warmers, large diapers, head covers, or electrode patches 3
Monitoring and Discontinuation
- Continue feeding every 2-3 hours during phototherapy to maintain adequate hydration 4, 5
- Monitor bilirubin levels regularly, with the following schedule:
- Phototherapy can be discontinued when serum bilirubin levels fall below 13-14 mg/dL 4, 5, 6
- Consider measuring TSB 24 hours after discharge to check for rebound hyperbilirubinemia, especially in infants with hemolytic disease 4, 5
Pharmacological Alternatives and Exchange Transfusion
- Intravenous immunoglobulin (0.5-1 g/kg over 2 hours) may be administered for infants with isoimmune hemolytic disease and rapidly rising TSB levels despite intensive phototherapy 4
- Exchange transfusion is indicated when TSB levels approach or exceed exchange level thresholds despite intensive phototherapy 4
- Immediate exchange transfusion is recommended for any infant showing signs of intermediate to advanced stages of acute bilirubin encephalopathy even if TSB is falling 4
Special Considerations
- For infants with hemolysis, phototherapy may be less effective and more intensive treatment may be required 1, 2
- In breastfed infants requiring phototherapy, feeding should be continued if possible, though temporary interruption with formula supplementation is an option to enhance efficacy 4
- Clinical response should be evident within 4-6 hours with an anticipated decrease of more than 2 mg/dL in serum bilirubin concentration 3